4.5 Article

Killed Saccharomyces cerevisiae Protects Against Lethal Challenge of Cryptococcus grubii

期刊

MYCOPATHOLOGIA
卷 178, 期 3-4, 页码 189-195

出版社

SPRINGER
DOI: 10.1007/s11046-014-9798-5

关键词

Cryptococcus grubii; Heat-killed yeast; Vaccine; Murine model; Systemic infection; Meningitis

类别

向作者/读者索取更多资源

Heat-killed Saccharomyces cerevisiae (HKY) vaccination protects mice against aspergillosis, coccidioidomycosis, mucormycosis, or candidiasis. We studied HKY protection against murine cryptococcosis. Once weekly subcutaneous HKY doses (S, 6 x 10(7); 2S, 1.2 x 10(8); 3S, 2.4 x 10(8)) began 28 (x3), 35 (x4), or 42 (x6) days prior to intravenous Cryptococcus grubii infection. Survival through 28 days, and CFU in the organs of survivors, were compared to saline-vaccinated controls. In the initial experiment, S, Sx4, or 2S reduced brain CFU; liver or spleen CFU was reduced by Sx4 or 2S. In a more lethal second experiment, 2Sx6, 2S, or 3Sx4 improved survival, and HKY regimens reduced CFU in the brain, liver, or spleen, with 2Sx6, 2S, or 3Sx4 most efficacious. Dose size appears more important than the number of doses: Regimens > S were superior, and 2S and 2Sx6 were equivalent. 2S and 3S were equivalent, suggesting doses > 2S do not provide additional protection. HKY protects against Cryptococcus, supporting components of HKY as a basis for the development of a panfungal vaccine.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据